Medical Patent News

RSS

India's Aurobindo Pharma first major generic drugmaker to Join UNITAID's Medicines Patent Pool

"India's Aurobindo Pharma has become the first major generic drugmaker to join" the Medicines Patent Pool, launched by the UNITAID health financing system and "designed to make HIV/AIDS treatments more widely available to the poor," Reuters reports.

12 Oct 2011

NIH, Genesis Biopharma enter Patent License Agreement for adoptive cell therapy

Genesis Biopharma, Inc., a biotechnology company developing targeted cancer immunotherapies, today announced it has entered into a Patent License Agreement with the National Institutes of Health, an agency of the United States Public Health Service within the Department of Health and Human Services

12 Oct 2011

PROLOR receives U.S. patent allowance for CTP-modified interferons

PROLOR Biotech, Inc. today announced that it received a notice of allowance from the U.S. Patent and Trademark Office (PTO) for a patent application covering PROLOR's CTP-modified interferons.

12 Oct 2011

NovaSterilis awarded patent for sterilization process for pharmaceutical API using supercritical carbon dioxide

NovaSterilis Inc., a developer of supercritical carbon dioxide technology, has been granted US Patent 8,012,414 B2. The patent, dated September 6, 2011 entitled “Sterilization of Drugs Using Supercritical Carbon Dioxide Sterilant”, covers a new and effective method of sterilizing pharmaceutical product without dangerous chemicals or radiation.

11 Oct 2011

ImmunoCellular receives U.S. patent allowance for ICT-107 to treat GBM

ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, announced the allowance of U.S. patent claims related to ICT-107, the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme.

11 Oct 2011

USPTO awards HistoRx two patents for methods of standardization of digital microscopy instruments

HistoRx, the leader in quantitative immunohistochemistry, advances its proprietary position in digital pathology through the recent issuance of US patents covering key features necessary for achievement of reproducible, standardized image analysis results.

7 Oct 2011

FBC Device receives US patent titled, 'Disc Implant'

FBC Device ApS, a medical device company developing the Statur line of spinal interbody fusion implants, has received its first US patent covering a series of two piece implants that enable natural spinal alignment. The Patent number US 8,007,536 is titled "Disc Implant."

3 Oct 2011

Subsidiary Acacia Research receives patents for heart valve technology

Acacia Research Corporation announced today that a subsidiary has acquired patents for heart valve technology from a major medical device company.

1 Oct 2011

AstraZeneca settles SEROQUEL XR patent infringement litigation

AstraZeneca today announced it has entered into a settlement agreement in its U.S. SEROQUEL XR patent infringement litigation against Handa Pharmaceuticals, LLC regarding Handa's proposed generic version of AstraZeneca's SEROQUEL XR extended-release tablets.

30 Sep 2011

USPTO issues patent to Precision BioSciences' engineered meganucleases

Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has issued U.S. Pat. No. 8,021,867. The '867 patent is owned by Duke University and exclusively licensed to Precision BioSciences.

27 Sep 2011

Isis files patent infringement lawsuit against Santaris for antisense drugs

Isis Pharmaceuticals, Inc. announced today it has filed a patent infringement lawsuit against Santaris Pharma A/S and Santaris Pharma A/S Corp. in the United States District Court of the Southern District of California.

26 Sep 2011

CytoDyn files provisional patent application for humanized version of Cytolin to treat HIV

CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, HIV/AIDS, announced today that it has filed a provisional patent application in the United States for its humanized version of its lead product Cytolin, a monoclonal antibody for the treatment of HIV infection.

26 Sep 2011

Momenta, Sandoz file patent suit against Amphastar and Watson over Enoxaparin Sodium Injection

Watson Pharmaceuticals, Inc. today confirmed that Momenta Pharmaceuticals, Inc. and Sandoz Inc. have filed suit against Amphastar Pharmaceuticals, Inc. and Watson on September 21, 2011 in the United States District Court for the District of Massachusetts.

23 Sep 2011

Adamis receives patents for APC-200 prostate cancer drug in South Africa, Singapore

Adamis Pharmaceuticals Corporation, today announced the technology which constitutes its compound APC-200 was recently granted patents in Singapore and South Africa. These patents significantly strengthen the Adamis APC-200 patent portfolio for the use of APC-200 in the treatment of early and late stage prostate cancer.

23 Sep 2011

USPTO issues patent for Lixte's LB-100 to treat cancer

John S. Kovach, M.D., Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc., announces that the United States Patent and Trademark Office awarded a patent on its lead compound, LB-100, as well as a number of structurally related compounds, which has shown promising anti-cancer activity.

23 Sep 2011

IRIDEX licenses rights to Ocunetics' intellectual property

IRIDEX Corporation today announced that it has exclusively licensed the rights to all of the intellectual property of Ocunetics, Inc., a privately held company based in Alamo, California. Ocunetics develops procedure-enabling medical devices that are intended to increase surgeons' efficiency, while improving case predictability for ophthalmic surgeries.

21 Sep 2011

NovaSterilis awarded patent for novel preparation and sterilization of ‘Green State’ devices

NovaSterilis Inc. has been granted US Patent No 7,988,892. The patent, dated August 2, 2011 is entitled “Preparation and Sterilization of Green State Devices Using a Supercritical Fluid Sterilant.”

19 Sep 2011

USPTO issues notice of allowance to Cenestra Health's omega-3 fatty acid formulations

The U.S. Patent and Trademark Office (USPTO) has issued a notice of allowance related to Cenestra Health's high-purity omega-3 fatty acid formulations and their methods of use.

19 Sep 2011

President's signing of America Invents Act a huge win for innovators

Today's historic signing of the America Invents Act represents a huge win for innovators and improves U.S. competiveness globally by aligning new patent laws more closely with those from other countries, said John Lechleiter, Ph.D., Chairman, President and Chief Executive Officer of Eli Lilly and Company.

17 Sep 2011

Life Technologies praises Obama's signing of the America Invents Act

Life Technologies Corporation applauds the signing by President Barack Obama of "The Leahy-Smith America Invents Act" (H.R. 1249). President Obama will sign the bill today at Thomas Jefferson High School for Science and Technology in Alexandria, Virginia.

16 Sep 2011

Medical Patent News

India's Aurobindo Pharma first major generic drugmaker to Join UNITAID's Medicines Patent Pool

NIH, Genesis Biopharma enter Patent License Agreement for adoptive cell therapy

PROLOR receives U.S. patent allowance for CTP-modified interferons

NovaSterilis awarded patent for sterilization process for pharmaceutical API using supercritical carbon dioxide

ImmunoCellular receives U.S. patent allowance for ICT-107 to treat GBM

USPTO awards HistoRx two patents for methods of standardization of digital microscopy instruments

FBC Device receives US patent titled, 'Disc Implant'

Subsidiary Acacia Research receives patents for heart valve technology

AstraZeneca settles SEROQUEL XR patent infringement litigation

USPTO issues patent to Precision BioSciences' engineered meganucleases

Isis files patent infringement lawsuit against Santaris for antisense drugs

CytoDyn files provisional patent application for humanized version of Cytolin to treat HIV

Momenta, Sandoz file patent suit against Amphastar and Watson over Enoxaparin Sodium Injection

Adamis receives patents for APC-200 prostate cancer drug in South Africa, Singapore

USPTO issues patent for Lixte's LB-100 to treat cancer

IRIDEX licenses rights to Ocunetics' intellectual property

NovaSterilis awarded patent for novel preparation and sterilization of ‘Green State’ devices

USPTO issues notice of allowance to Cenestra Health's omega-3 fatty acid formulations

President's signing of America Invents Act a huge win for innovators

Life Technologies praises Obama's signing of the America Invents Act

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News